FDA Clears Chewable Methylphenidate (QuilliChew) for ADHDFDA Clears Chewable Methylphenidate (QuilliChew) for ADHD
QuilliChew extended-release (Pfizer) is for treatment of attention-deficit/hyperactivity disorder (ADHD) in children aged 6 years and older. FDA Approvals
Source: Medscape Psychiatry Headlines - Category: Psychiatry Tags: Psychiatry News Alert Source Type: news
More News: ADHD | Children | Concerta | Hyperactivity | Methylphenidate | Pfizer | Psychiatry | Ritalin